000766 通化金马
已收盘 11-19 15:00:00
资讯
新帖
简况
通化金马:董秘回答关于具有融资融券业务的证券公司
问董秘 · 11-12
通化金马:董秘回答关于具有融资融券业务的证券公司
通化金马(000766)2024年三季报简析:净利润增53.84%
证券之星 · 10-22
通化金马(000766)2024年三季报简析:净利润增53.84%
通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%
智通财经 · 10-20
通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%
通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%
证券之星 · 10-20
通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%
图解通化金马三季报:第三季度单季净利润同比增139.97%
证券之星 · 10-20
图解通化金马三季报:第三季度单季净利润同比增139.97%
通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%
证券之星 · 10-20
通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%
通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护
证券之星 · 10-15
通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护
通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理
智通财经 · 10-15
通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理
10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股
证券之星 · 10-14
10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股
10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股
证券之星 · 10-09
10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股
通化金马(000766)10月8日主力资金净卖出2.19亿元
证券之星 · 10-09
通化金马(000766)10月8日主力资金净卖出2.19亿元
通化金马(000766)9月30日主力资金净卖出1.07亿元
证券之星 · 10-08
通化金马(000766)9月30日主力资金净卖出1.07亿元
9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股
证券之星 · 09-30
9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股
通化金马的阿尔茨海默新药赌局
媒体滚动 · 09-25
通化金马的阿尔茨海默新药赌局
A股创新药板块持续反弹,海创药业涨超15%,广生堂涨超10%,罗欣药业、圣诺生物、通化金马、普利制药等跟涨。
美港电讯 · 09-19
A股创新药板块持续反弹,海创药业涨超15%,广生堂涨超10%,罗欣药业、圣诺生物、通化金马、普利制药等跟涨。
9月13日通化金马现1笔大宗交易 机构净买入312.11万元
证券之星 · 09-13
9月13日通化金马现1笔大宗交易 机构净买入312.11万元
通化金马:请查阅国家相关政策
证券之星 · 09-13
通化金马:请查阅国家相关政策
通化金马:受理通知书是此项申请被国家药品监督管理局受理的证明文件,非公示文件
证券之星 · 09-11
通化金马:受理通知书是此项申请被国家药品监督管理局受理的证明文件,非公示文件
通化金马(000766)9月10日主力资金净卖出1446.52万元
证券之星 · 09-11
通化金马(000766)9月10日主力资金净卖出1446.52万元
通化金马:相关工作正在推进中,涉及新药的重大信息,均会在指定信息披露媒体发布,请投资者关注公司公告
证券之星 · 09-10
通化金马:相关工作正在推进中,涉及新药的重大信息,均会在指定信息披露媒体发布,请投资者关注公司公告
加载更多
公司概况
公司名称:
通化金马药业集团股份有限公司
所属行业:
医药制造业
上市日期:
1997-04-30
主营业务:
通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。
发行价格:
7.23
{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"通化金马","latestPrice":14.42,"timestamp":1731999807000,"preClose":14.02,"halted":0,"volume":13239969,"delay":0,"floatShares":966000000,"shares":966000000,"eps":0.0542,"marketStatus":"已收盘","marketStatusCode":5,"change":0.4,"latestTime":"11-19 15:00:00","open":14.06,"high":14.43,"low":13.98,"amount":188000000,"amplitude":0.0321,"askPrice":14.43,"askSize":360,"bidPrice":14.42,"bidSize":23,"shortable":0,"etf":0,"ttmEps":0.0542,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":14.02,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":15.42,"lowLimit":12.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"pbRate":5.79,"roa":"--","roe":"1.03%","epsLYR":0.05,"committee":-0.148863,"marketValue":13937000000,"floatMarketCap":13930000000,"peRate":266.051655,"changeRate":0.0285,"turnoverRate":0.0137,"status":0},"requestUrl":"/m/hq/s/000766","defaultTab":"news","newsList":[{"id":"2482934721","title":"通化金马:董秘回答关于具有融资融券业务的证券公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2482934721","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482934721?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:57","pubTimestamp":1731398220,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 投资者提问:哪家证券可以融券贵公司有价证券?董秘回答(通化金马SZ000766):您好,请咨询具有融资融券业务的证券公司。查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-12/doc-incvuxsf9519286.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-12/doc-incvuxsf9519286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159848","BK0060","000766","399975","BK0239","BK0077"],"gpt_icon":0},{"id":"2477481006","title":"通化金马(000766)2024年三季报简析:净利润增53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477481006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477481006?lang=zh_cn&edition=full","pubTime":"2024-10-22 06:02","pubTimestamp":1729548175,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期通化金马发布2024年三季报。根据财报显示,通化金马净利润增53.84%。截至本报告期末,公司营业总收入9.69亿元,同比下降7.24%,归母净利润2392.37万元,同比上升53.84%。按单季度数据看,第三季度营业总收入3.19亿元,同比上升1.16%,第三季度归母净利润1145.54万元,同比上升139.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200003826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2476084593","title":"通化金马(000766.SZ)发布前三季度业绩,净利润2392.37万元,增长53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476084593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476084593?lang=zh_cn&edition=full","pubTime":"2024-10-20 17:17","pubTimestamp":1729415872,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通化金马(000766.SZ)发布2024年三季度报告,该公司前三季度营业收入为9.69亿元,同比减少7.24%。归属于上市公司股东的净利润为2392.37万元,同比增长53.84%。归属于上市公司股东的扣除非经常性损益的净利润为1638.78万元,同比增长51.15%。基本每股收益为0.0248元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000766"],"gpt_icon":0},{"id":"2476081611","title":"通化金马(000766)9月30日股东户数4.92万户,较上期增加2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476081611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476081611?lang=zh_cn&edition=full","pubTime":"2024-10-20 17:00","pubTimestamp":1729414844,"startTime":"0","endTime":"0","summary":"证券之星消息,近日通化金马披露,截至2024年9月30日公司股东户数为4.92万户,较6月30日增加1402.0户,增幅为2.93%。在化学制药行业个股中,通化金马股东户数高于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.18万户。从股价来看,2024年6月30日至2024年9月30日,通化金马区间涨幅为2.1%,在此期间股东户数增加1402.0户,增幅为2.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000001250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0077","BK0060","BK0239"],"gpt_icon":0},{"id":"2476086688","title":"图解通化金马三季报:第三季度单季净利润同比增139.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476086688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476086688?lang=zh_cn&edition=full","pubTime":"2024-10-20 16:31","pubTimestamp":1729413101,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马2024年三季报显示,公司主营收入9.69亿元,同比下降7.24%;归母净利润2392.37万元,同比上升53.84%;扣非净利润1638.78万元,同比上升51.15%;其中2024年第三季度,公司单季度主营收入3.19亿元,同比上升1.16%;单季度归母净利润1145.54万元,同比上升139.97%;单季度扣非净利润998.64万元,同比上升218.77%;负债率49.06%,投资收益327.52万元,财务费用5735.92万元,毛利率75.39%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000001167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2476836620","title":"通化金马最新公告:前三季度净利润2392.37万元 同比增长53.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476836620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476836620?lang=zh_cn&edition=full","pubTime":"2024-10-20 16:00","pubTimestamp":1729411249,"startTime":"0","endTime":"0","summary":"通化金马发布2024年第三季度报告,前三季度实现营业收入9.69亿元,同比下降7.24%;归属于上市公司股东的净利润2392.37万元,同比增长53.84%;基本每股收益0.0248元。其中,第三季度归属于上市公司股东的净利润1145.54万元,同比增长139.97%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000000997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766"],"gpt_icon":0},{"id":"2475520703","title":"通化金马最新公告:琥珀八氢氨吖啶片获15国PCT专利保护","url":"https://stock-news.laohu8.com/highlight/detail?id=2475520703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475520703?lang=zh_cn&edition=full","pubTime":"2024-10-15 18:21","pubTimestamp":1728987662,"startTime":"0","endTime":"0","summary":"通化金马发布关于国家1类化学药琥珀八氢氨吖啶片相关专利保护情况的自愿性披露公告,琥珀八氢氨吖啶片是一种新型的、强效、作用机制明确的胆碱酯酶抑制剂,是拥有完全自主知识产权、新化学分子结构的化学1类新药,用于轻、中度阿尔茨海默病的治疗。同时,琥珀八氢氨吖啶主要晶型陆续获得国际PCT(专利合作条约)专利保护,其中2022年9月获得日本专利授权。2023年5月获得欧洲授权,具体国家为以下15国:英国、德国、瑞士、瑞典、荷兰、丹麦、芬兰、比利时、法国、奥地利、西班牙、挪威、爱尔兰、希腊、意大利。于2024年9月获得美国专利授权。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101500029704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000766","BK0077","BK0239","BK0060"],"gpt_icon":0},{"id":"2475858525","title":"通化金马(000766.SZ):琥珀八氢氨吖啶片的原料药和制剂已获国家药监局上市申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2475858525","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475858525?lang=zh_cn&edition=full","pubTime":"2024-10-15 17:10","pubTimestamp":1728983453,"startTime":"0","endTime":"0","summary":"公司研发的琥珀八氢氨吖啶片的原料药和制剂已获得国家药品监督管理局上市申请受理,进入国家药品监督管理局药品审评中心审评审批环节,药品审评审批时间、审批结果及未来产品市场竞争形势均存在诸多不确性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0060","BK0077","000766"],"gpt_icon":0},{"id":"2475344193","title":"10月14日通化金马涨7.45%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475344193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475344193?lang=zh_cn&edition=full","pubTime":"2024-10-14 16:16","pubTimestamp":1728893797,"startTime":"0","endTime":"0","summary":"证券之星消息,10月14日通化金马涨7.45%,收盘报15.28元,换手率3.56%,成交量34.41万手,成交额5.06亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF目前规模为241.3亿元,最新净值2.2019,较上一交易日下跌4.22%,近一年下跌9.71%。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400019217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0060","000766","560110","BK0239"],"gpt_icon":0},{"id":"2474216287","title":"10月9日通化金马跌9.90%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474216287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474216287?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:14","pubTimestamp":1728465269,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日通化金马跌9.90%,收盘报14.93元,换手率4.89%,成交量47.24万手,成交额7.3亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900030915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0077","000766","560110"],"gpt_icon":0},{"id":"2474823777","title":"通化金马(000766)10月8日主力资金净卖出2.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474823777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474823777?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:23","pubTimestamp":1728437039,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月8日收盘,通化金马报收于16.57元,上涨0.24%,换手率7.32%,成交量70.73万手,成交额11.93亿元。10月8日的资金流向数据方面,主力资金净流出2.19亿元,占总成交额18.33%,游资资金净流入1.07亿元,占总成交额9.01%,散户资金净流入1.11亿元,占总成交额9.32%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入1.01亿元,融资偿还1.18亿元,融资净偿还1626.47万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900005766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0060","000766","BK0239"],"gpt_icon":0},{"id":"2473457604","title":"通化金马(000766)9月30日主力资金净卖出1.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473457604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473457604?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:21","pubTimestamp":1728350477,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月30日收盘,通化金马报收于16.53元,上涨6.71%,换手率5.67%,成交量54.78万手,成交额8.9亿元。9月30日的资金流向数据方面,主力资金净流出1.07亿元,占总成交额12.02%,游资资金净流入996.92万元,占总成交额1.12%,散户资金净流入9703.67万元,占总成交额10.9%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入6168.46万元,融资偿还6428.42万元,融资净偿还259.96万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800001442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","000766","BK0239"],"gpt_icon":0},{"id":"2471874925","title":"9月30日通化金马涨6.71%,南方中证1000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2471874925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471874925?lang=zh_cn&edition=full","pubTime":"2024-09-30 17:54","pubTimestamp":1727690081,"startTime":"0","endTime":"0","summary":"证券之星消息,9月30日通化金马涨6.71%,收盘报16.53元,换手率5.67%,成交量54.78万手,成交额8.9亿元。重仓通化金马的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为南方中证1000ETF。南方中证1000ETF的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024093000031546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","560110","BK0077","000766","BK0060"],"gpt_icon":0},{"id":"2470663448","title":"通化金马的阿尔茨海默新药赌局","url":"https://stock-news.laohu8.com/highlight/detail?id=2470663448","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470663448?lang=zh_cn&edition=full","pubTime":"2024-09-25 02:08","pubTimestamp":1727201280,"startTime":"0","endTime":"0","summary":"近期,通化金马成为二级市场上的一匹黑马,接连斩获多个涨停,在一个月间股价实现翻倍。通化金马此轮大涨背后的诱因,则是公司在研的一款用于治疗阿尔茨海默症新药,即琥珀八氢氨吖啶片项目近期取得重大进展,已宣布Ⅲ期临床试验揭盲结果。值得注意的是,阿尔茨海默症一直被视为医药研发界的“天坑”,相较于市场的高预期,通化金马研发的这款新药前景如何仍是一个未知数。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/chanjing/gsnews/2024-09-25/doc-incqhync4237735.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/chanjing/gsnews/2024-09-25/doc-incqhync4237735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0239","000766","BK0060"],"gpt_icon":0},{"id":"2468577514","title":"A股创新药板块持续反弹,海创药业涨超15%,广生堂涨超10%,罗欣药业、圣诺生物、通化金马、普利制药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2468577514","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468577514?lang=zh_cn&edition=full","pubTime":"2024-09-19 13:18","pubTimestamp":1726723093,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300436","300630","000766","002793","BK1574","399300","688302","08058","688117","BK0077","BK0060","BK0001","BK1161","06978","BK0201","159982","BK0132","159992","BK0239"],"gpt_icon":0},{"id":"2467774373","title":"9月13日通化金马现1笔大宗交易 机构净买入312.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467774373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467774373?lang=zh_cn&edition=full","pubTime":"2024-09-13 17:04","pubTimestamp":1726218246,"startTime":"0","endTime":"0","summary":"证券之星消息,9月13日通化金马发生大宗交易,交易数据如下:大宗交易成交价格13.57元,成交23万股,成交金额312.11万元,买方营业部为机构专用,卖方营业部为中信建投证券股份有限公司福清福和路证券营业部。近三个月该股共发生2笔大宗交易,合计成交4600.0手。该股近期无解禁股上市。截至2024年9月13日收盘,通化金马(000766)报收于13.57元,下跌3.07%,换手率1.33%,成交量12.82万手,成交额1.78亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300026964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0},{"id":"2467976616","title":"通化金马:请查阅国家相关政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2467976616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467976616?lang=zh_cn&edition=full","pubTime":"2024-09-13 10:02","pubTimestamp":1726192968,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马(000766)09月13日在投资者关系平台上答复投资者关心的问题。投资者:创新药有哪些扶持政策?通化金马董秘:您好,请查阅国家相关政策。投资者:近3年全国创新药有多少研发成功的?通化金马董秘:您好,相关数据请以国家药品监督管理局公布的数据为准。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091300009756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0060","000766"],"gpt_icon":0},{"id":"2466408846","title":"通化金马:受理通知书是此项申请被国家药品监督管理局受理的证明文件,非公示文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2466408846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466408846?lang=zh_cn&edition=full","pubTime":"2024-09-11 17:19","pubTimestamp":1726046346,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马09月11日在投资者关系平台上答复投资者关心的问题。新药受理后公司按照国家有关规定程序,开展上市申请和审评审批工作,公司将根据进展情况及时履行信息披露义务。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100029045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","000766","BK0239"],"gpt_icon":0},{"id":"2466438494","title":"通化金马(000766)9月10日主力资金净卖出1446.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466438494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466438494?lang=zh_cn&edition=full","pubTime":"2024-09-11 09:23","pubTimestamp":1726017809,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月10日收盘,通化金马报收于14.19元,下跌1.94%,换手率1.43%,成交量13.81万手,成交额1.96亿元。9月10日的资金流向数据方面,主力资金净流出1446.52万元,占总成交额7.37%,游资资金净流入1044.05万元,占总成交额5.32%,散户资金净流入402.47万元,占总成交额2.05%。近5日资金流向一览见下表:通化金马融资融券信息显示,融资方面,当日融资买入2217.12万元,融资偿还1352.35万元,融资净买入864.77万元。通化金马主营业务:医药产品的研发、生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091100009292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","000766","BK0077","BK0239"],"gpt_icon":0},{"id":"2466489700","title":"通化金马:相关工作正在推进中,涉及新药的重大信息,均会在指定信息披露媒体发布,请投资者关注公司公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2466489700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466489700?lang=zh_cn&edition=full","pubTime":"2024-09-10 17:04","pubTimestamp":1725959078,"startTime":"0","endTime":"0","summary":"证券之星消息,通化金马09月10日在投资者关系平台上答复投资者关心的问题。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000027417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000766","BK0077","BK0060"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","stockEarnings":[{"period":"1week","weight":-0.1059},{"period":"1month","weight":-0.0937},{"period":"3month","weight":0.0309},{"period":"6month","weight":-0.1372},{"period":"1year","weight":-0.0672},{"period":"ytd","weight":-0.2969}],"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","perCapita":"19615股","boardName":"医药制造业","registeredCapital":"96649万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 通化金马药业集团股份有限公司主要从事医药产品的研发、生产与销售。主要产品有复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾口服液、芩石利咽口服液。公司经历多年发展,获得行业认可,荣获“中华民族医药百强品牌企业”,2023年获得“2022-2023年度中国医药制造业百强”等称号。子公司圣泰生物先后被评为哈尔滨市“小巨人”企业、黑龙江省民营科技“巨星”企业、黑龙江省专精特新小巨人企业、国家高新技术企业、国家火炬计划重点高新技术企业等多项荣誉。","serverTime":1732012139964,"listedPrice":7.23,"stockholders":"49247人(较上一季度增加2.93%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化金马,000766,通化金马股票,通化金马股票老虎,通化金马股票老虎国际,通化金马行情,通化金马股票行情,通化金马股价,通化金马股市,通化金马股票价格,通化金马股票交易,通化金马股票购买,通化金马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化金马(000766)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化金马(000766)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}